financetom
Business
financetom
/
Business
/
Stellantis-backed battery maker ACC halts plans for German, Italian plants
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Stellantis-backed battery maker ACC halts plans for German, Italian plants
Jun 4, 2024 7:19 AM

PARIS, June 4 (Reuters) - ACC, a battery joint venture

backed by carmakers Stellantis ( STLA ) and Mercedes

, has halted plans for factories in Germany and Italy

as the company switches to lower cost batteries amid slowing

demand for electric vehicles.

The company said on Tuesday it needed to research and

develop low-cost batteries to supply cheaper EVs and that it

would renew discussions on its factory in Italy's Termoli in

late 2024 or early 2025.

ACC also confirmed plans to halt construction of a factory

in Germany's Kaiserslautern, first reported by German media Die

Rheinpfalz on Monday.

Growth in Europe's EV market has slowed significantly, with

high interest rates and slashed government subsidies pushing

consumers to opt for hybrids or petrol cars instead.

"We are going to adjust our investment plans on EVs to the

pace at which market sales of EVs grow," said Stellantis ( STLA ) CEO

Carlos Tavares, in response to a question at a media briefing on

whether ACC still plans to build three factories in Europe.

The company is currently ramping up production of its first

factory in northern France.

ACC, is 45%-owned by Stellantis ( STLA ) and Mercedes holds a 30%

stake. Saft, a battery subsidiary of France's TotalEnergies

, owns 25% of the company.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Salesforce Insider Sold Shares Worth $2,133,803, According to a Recent SEC Filing
Salesforce Insider Sold Shares Worth $2,133,803, According to a Recent SEC Filing
Dec 26, 2024
05:01 PM EST, 12/26/2024 (MT Newswires) -- Amy E Weaver, President and CFO, on December 24, 2024, sold 6,221 shares in Salesforce ( CRM ) for $2,133,803. Following the Form 4 filing with the SEC, Weaver has control over a total of 53,861 shares of the company, with 53,861 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1108524/000112760224030073/xslF345X05/form4.xml ...
Hongli Group Files Secondary Stock Shelf
Hongli Group Files Secondary Stock Shelf
Dec 26, 2024
05:04 PM EST, 12/26/2024 (MT Newswires) -- Hongli Group ( HLP ) late Thursday filed a preliminary prospectus for secondary sale by investors from time to time of 60 million ordinary shares they acquired from the Chinese steel producer in November. Hongli ( HLP ) on Nov. 13 issued 60 million shares priced at $0.55 apiece for $33 million. The...
NuScale Power Raises $227.7 Million From Warrant Exercise
NuScale Power Raises $227.7 Million From Warrant Exercise
Dec 26, 2024
05:01 PM EST, 12/26/2024 (MT Newswires) -- NuScale Power ( SMR ) said late Thursday about 97% of its warrants were exercised by holders to buy its class A shares at $11.50 per share at redemption date, raising $227.7 million for the firm. The company said no warrants remained outstanding and they have ceased trading on the New York Stock...
Viracta Therapeutics Exploring Options, Including Potential Sale; Closes Phase 2 Trial of Nana-val
Viracta Therapeutics Exploring Options, Including Potential Sale; Closes Phase 2 Trial of Nana-val
Dec 26, 2024
05:02 PM EST, 12/26/2024 (MT Newswires) -- Viracta Therapeutics ( VIRX ) said late Thursday its board has launched a process to explore options, including a potential merger, sale or licensing deal. While the board reviews Viracta's options, the company said it has decided to close its phase 2 trial of Nana-val for the treatment of relapsed/refractory EBV+ lymphomas to...
Copyright 2023-2026 - www.financetom.com All Rights Reserved